Joseph P. Lyssikatos
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Enliven Therapeutics, Inc. (ELVN)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Enliven Therapeutics, Inc. (ELVN) | Chief Scientific Officer | $470,000 | $2,734,410 |
| 2023 | Enliven Therapeutics, Inc. (ELVN) | Chief Scientific Officer | $436,502 | $4,010,749 |
| 2022 | Enliven Therapeutics, Inc. (ELVN) | Chief Scientific Officer | $350,000 | $535,770 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.